Hans van der Leer
Translator — Dutch
The Netherlands
Articles translated into Dutch by Hans van der Leer
- The 2013 HDBuzz Prize for Young Science Writers
- Could muscle problems help explain movements in Huntington’s Disease patients?
- Does a 'rusty hinge' cause Huntington's disease?
- How long is too long? Rethinking the Huntington’s disease ‘gray area’
- A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
- Start here!
- Gene silencing drug safe in ALS patients... bring on Huntington's disease trials
- Landmark study puts Huntington's disease trials on TRACK
- No surprises in published results from HART study of Huntexil for Huntington's disease
- 'Floating' gene-silencing drugs into the brain with exosomes
- Video: What’s new in Huntington's disease research 2012
- HDBuzz Special Feature: Huntington's disease and sleep
- Interview: CHDI Management
- EuroBuzz Video: Day 1
- Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
- The University of New Orleans has NOT discovered a cure for Huntington's disease
- Giving Huntington's disease the finger? Two teams report success for zinc-finger drugs in cells and mice
- 'Guard dog' proteins reveal surprising connections between Huntington's disease and other brain disorders
- EuroBuzz News: Day 1
- HDBuzz Prize runner-up 2012: Fruit flies, faulty connections and Huntington's disease
- HD Therapeutics Conference 2012 Updates: Day 3
- Of mice and men: using animal models to study Huntington's disease
- Coming soon: HD Therapeutics Conference 2012
- HD Therapeutics Conference 2012 Updates: Day 2
- Interview: Alice and Nancy Wexler
- Shooting the messenger with single-stranded RNA gene silencing
- High-power brain scans reveal sodium changes in HD
- Illuminating findings in blood cells from Huntington's disease patients
- CHDI Report: Day 3
- CHDI Report: Day 1
- CHDI Report: Day 2
- New experiments clarify the role of SIRT1 in HD - or do they?
- HDBuzz takes your questions to the annual therapeutics meeting of CHDI
- Getting the data out – a new scientific journal just for HD
- Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
- Memantine in HD: dose is everything
- Anti-nausea drug helps cells with the HD mutation stay healthy in a surprising way
- Dimebon: disappointing in Alzheimer’s but might work in HD
- Therapeutics conference videos now online
- HD Therapeutics Conference 2012 Updates: Day 1